Completed
Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)
NCT00840931
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States